ALUMINUM STEARATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	3C18H35O2.Al
Molecular Weight	877.3894
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O

InChI

InChIKey=CEGOLXSVJUTHNZ-UHFFFAOYSA-K

InChI=1S/3C18H36O2.Al/c3*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h3*2-17H2,1H3,(H,19,20);/q;;;+3/p-3

HIDE SMILES / InChI

Description
Sources: https://www.drugs.com/inactive/aluminum-stearate-184.html | https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htmhttp://www.doiserbia.nb.rs/img/doi/1450-7188/2003/1450-71880334055L.pdf
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25063173 | https://www.ncbi.nlm.nih.gov/pubmed/967230 | https://www.ncbi.nlm.nih.gov/pubmed/1234981 | https://www.ncbi.nlm.nih.gov/pubmed/374763

Because of its unusually heavy bodying properties, aluminum monostearate is used in the manufacture of paints, inks, greases, and waxes In recent years, hydrophobic aluminum monostearate was tested as a low-solubility denitrification substrate for anaerobic bacteria and a source of aluminum for phosphate precipitation. Aluminum monostearate can be used as a component of vehicle for delivery of drugs.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Angina pectoris due to coronary artery disease 3 Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020215s024lbl.pdf	Inactive ingredient		Approved 8429	Monoket Approved Use Monoket® is indicated for the prevention and treatment of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. Launch Date 1991
Unknown 2578

PubMed

Title	Date	PubMed
Long-acting narcotic antagonist complexes.	1975	1234981
Penicillin levels in blood and CSF achieved by treatment of syphilis.	1979 Jun 8	374763
Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of eudragit RS microspheres.	2006 Feb 24	16584146
Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of Eudragit RS microspheres.	2006 Mar	28290031
Metal stearate distributions in modern artists' oil paints: surface and cross-sectional investigation of reference paint films using conventional and synchrotron infrared microspectroscopy.	2012 Oct	23031696
Hydrophobic chitosan sponges modified by aluminum monostearate and dehydrothermal treatment as sustained drug delivery system.	2014 Sep	25063173

Patents

Sample Use Guides

In Vivo Use Guide

topical use

Route of Administration: Topical

In Vitro Use Guide

Unknown

Name

Type

Language

ALUMINUM STEARATE

Systematic Name

English

ALUMINUM STEARATE [VANDF]

Common Name

English

ALUMINIUM STEARATE [EP MONOGRAPH]

Common Name

English

ALUGEL 34TH

Common Name

English

ALUMINIUM STEARATE

Systematic Name

English

ALUMINUM TRISTEARATE

Official Name

English

ALUMINUM TRISTEARATE [INCI]

Common Name

English

ALUGEL 34TN

Common Name

English

ALUGEL 30DF

Common Name

English

ALUMINIUM TRISTEARATE

Systematic Name

English

OCTADECANOIC ACID, ALUMINUM SALT (3:1)

Common Name

English

THOMPSON'S WATER SEAL

Common Name

English

ALUMINUM TRISTEARATE [HSDB]

Common Name

English

Aluminium stearate [WHO-DD]

Common Name

English

ALUMINUM STEARATE [MI]

Common Name

English

ALUMINUM STEARATE [II]

Common Name

English

Classification Tree Code System Code

CFR

21 CFR 175.210